Erythropoietin therapy tied to hip-fracture risk in patients on dialysis
For patients on a high dose it appears to be on a par with other well-known risk factors, authors say.
Tag: Haematology
Scientists claim to have solved the mystery of AstraZeneca vax blood clots
They’ve implicated the adenovirus vector’s delivery mechanism in ‘mimicking’ COVID-19.
TGA investigates cardiac adverse events linked to mRNA vaccines
Heart specialists in the US say the risk is minor compared with the risk of COVID-19.
Five clot cases in over-50s linked to AstraZeneca vaccine
It takes the total in Australia to 11, from 1.4 million vaccine doses.
Blood bank plans rethink on UK donor ban
Lifeblood - a branch of the Australian Red Cross - is preparing a TGA submission to reconsider ban on British blood donors.
Clot risk ’10 times higher’ with COVID-19 than vaccines
Researchers have provided a rule of thumb guide to the absolute incidence of rare clotting events.
Is AstraZeneca’s adenovirus technology behind the blood clots?
This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take…
Is the AstraZeneca vaccine’s adenovirus vector causing the rare blood clots?
Case studies in Europe suggest an autoimmune reaction occurs that’s similar to heparin-induced thrombocytopenia.
GPs need more funding to manage vaccine clot fears, RACGP says
College president Dr Karen Price argues new ATAGI advice on the AstraZeneca vaccine will 'add complications to the whole process'.
GPs face patient consent headaches after ATAGI revamps vaccine advice
Pfizer's vaccine is 'preferred' to AstraZeneca's for under-50s: ATAGI.
